[go: up one dir, main page]

CL2011000143A1 - Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico. - Google Patents

Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.

Info

Publication number
CL2011000143A1
CL2011000143A1 CL2011000143A CL2011000143A CL2011000143A1 CL 2011000143 A1 CL2011000143 A1 CL 2011000143A1 CL 2011000143 A CL2011000143 A CL 2011000143A CL 2011000143 A CL2011000143 A CL 2011000143A CL 2011000143 A1 CL2011000143 A1 CL 2011000143A1
Authority
CL
Chile
Prior art keywords
composition
wounds
calendula
propolis
prepare
Prior art date
Application number
CL2011000143A
Other languages
English (en)
Inventor
G Elmo Moreno
F Nieves Galdames
Original Assignee
Muciderm S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muciderm S A filed Critical Muciderm S A
Priority to CL2011000143A priority Critical patent/CL2011000143A1/es
Priority to PCT/CL2011/000031 priority patent/WO2012097466A1/es
Priority to US13/980,735 priority patent/US9125964B2/en
Publication of CL2011000143A1 publication Critical patent/CL2011000143A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Insects & Arthropods (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA CONFORMADA POR BABA DE CARACOL HELIX ASPERSA MULLER (CRYPTOPHALUS ASPERSUS) (15% A 30%) Y ADITIVOS Y/O EXCIPIENTES FARMACEUTICAMENTE ACEPTABI ES PARA CONFORMAR UNA FORMULACION DE VISCOSIDAD DE 200 A 1000 PA-5. DICHA COMPOSICION EN FORMA DE CREMA O GEL SE ENCUENTRA EMBEBIDA EN TELA TIPO GASA EN FORMA DE PARCHE, VENDA O CALCETIN (SIN ADHESIVOS) PARA SER APLICADA SOBRE HERIDAS ULCEROSAS DE PIE DIABETICO. LA COMPOSICION CONTIENE COMO COMPONENTES ESENCIALES 3-5 0/o DE EXTRACTO NATURAL DE CALENDULA, PROPOLEO Y/O ACEITE DE ALMENDRAS. SE REIVINDICA ADEMAS EL PROCEDIMIENTO DE OBTENCION DE LA COMPOSICION Y SU USO PARA PREPARAR UN MEDICAMENTO O DISPOSITIVO PARA PREVENIR O TRATAR AFECCIONES DE TIPO ULCERAS O HERIDAS DE PIE DIABFTICO.
CL2011000143A 2011-01-21 2011-01-21 Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico. CL2011000143A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2011000143A CL2011000143A1 (es) 2011-01-21 2011-01-21 Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.
PCT/CL2011/000031 WO2012097466A1 (es) 2011-01-21 2011-05-20 Composición farmacéutica y dispositivo para la prevención, tratamiento y curación de úlceras de pié diabético y otras heridas, que comprende baba de caracol de la especie cryptophalus aspersus o helix aspersa müller y excipientes y/o aditivos farmacéuticamente aceptables
US13/980,735 US9125964B2 (en) 2011-01-21 2011-05-20 Pharmaceutical composition and device for preventing, treating and curing ulcers on a diabetic foot and other wounds, which includes snail slime from the species Cryptophalus aspersus or Helix aspersa muller and pharmaceutically acceptable carriers and/or additives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2011000143A CL2011000143A1 (es) 2011-01-21 2011-01-21 Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.

Publications (1)

Publication Number Publication Date
CL2011000143A1 true CL2011000143A1 (es) 2012-01-06

Family

ID=46515059

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000143A CL2011000143A1 (es) 2011-01-21 2011-01-21 Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.

Country Status (3)

Country Link
US (1) US9125964B2 (es)
CL (1) CL2011000143A1 (es)
WO (1) WO2012097466A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2014002248A1 (es) 2014-08-25 2014-10-17 Muciderm S A Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.
CL2014002729A1 (es) * 2014-10-10 2014-12-19 Muciderm S A Composicion farmaceutica conformada por baba de caracol helix aspersa müller (20-50%), extracto de manzanilla (1-4%), propoleo (1-4%) y aditivos y/o excipientes, con una viscosidad de 10 a 1000 pa-s, en forma de locion, crema, jabon o gel; procedimiento para obtenerla; y su uso para prevenir o tratar patologias de la rosacea.
EP3124030B1 (en) * 2015-07-30 2022-03-16 Aristotle University Of Thessaloniki-Research Committee Method for producing a snail extract from cornu aspersum and its extract
CN105381262A (zh) * 2015-12-28 2016-03-09 宋瑄 一种治疗糖尿病足的外用中药组合物
EP3946281A1 (en) 2019-04-02 2022-02-09 Alma Mater Studiorum - Università di Bologna Polymer films comprising material secreted by gastropods
IT201900010827A1 (it) * 2019-07-04 2019-10-04 C T S V S R L Bava di lumaca liofilizzata, uso di tale bava e prodotti ottenuti da essa
CN113209360B (zh) * 2021-03-09 2022-02-01 吉林大学 一种促进伤口愈合的医用粘合剂及其制备方法
IT202100018146A1 (it) * 2021-07-09 2023-01-09 Kms Soc Agricola S R L Uso di estratti di helix come fattore pro-angiogenico o vascolarizzante
CN114848739B (zh) * 2022-02-09 2024-03-15 高一涵 一种中草药贴剂
CN114452181A (zh) * 2022-02-22 2022-05-10 河南省人民医院 用于糖尿病足的皮肤外用物及其制备方法
EP4316535B1 (en) 2022-08-02 2024-11-20 Marija Glavash Dodov Wound healing composition containing snail mucus
IT202200019143A1 (it) 2022-09-19 2024-03-19 Gruppo Italiano Cosmesi Spa Soc Benefit In Breve Gic Spa S B Composizione cosmetica a base di bava di lumaca e di un estratto vegetale da fieno

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0531495B1 (en) * 1991-03-01 1997-08-20 Atherton Investments, Ltd. Therapeutic and cosmetic compositions for treatment of skin
BR9205713A (pt) * 1991-03-01 1994-06-07 Atherton Investments Ltd Ingrediente ativo de secreçao de gastrópode, processo para sua preparaçao, e composiçao de ingrediente ativo
DE19921027A1 (de) * 1999-05-07 2000-11-09 Studiengesellschaft Kohle Mbh Verbindungen mit antibiotischer Wirkung
US20050037034A1 (en) * 2003-05-05 2005-02-17 Rhoades Dean L. Method, apparatus, and composition for treating acne
TW200512007A (en) * 2003-05-30 2005-04-01 Fullerene Internat Corp Cosmetic compositions containing fullerene clusters
US20050266064A1 (en) * 2004-05-29 2005-12-01 Mccarthy Kathryn J Cosmetic compositions and methods
US7879343B2 (en) * 2005-12-16 2011-02-01 Alkazemi Wafa M A R Burn treatment method and composition
US20070248633A1 (en) * 2006-04-21 2007-10-25 L'oreal Compositions containing a hydroxylated diphenylmethane compound, methods of use
WO2009002982A2 (en) * 2007-06-23 2008-12-31 Pharmacom International Inc. Gastropod biological fluid, method of making and refining and use
US20100233111A1 (en) * 2008-04-06 2010-09-16 William Wang Gastropod biological fluid, method of making and refining and use

Also Published As

Publication number Publication date
US20130309296A1 (en) 2013-11-21
WO2012097466A1 (es) 2012-07-26
US9125964B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
CL2011000143A1 (es) Composicion farmaceutica que comprende baba de caracol helix aspersa müller disuelta en una base de crema de cuerpo, extracto natural de calendula y propoleo o aceite de almendras; procedimiento de obtencion de la composicion; y su uso para preparar un medicamento o dispositivo util para prevenir o tratar afecciones tipo ulceras o heridas, tal como ulceras o heridas de pie diabetico.
CL2017002939A1 (es) Composiciones farmacéuticas tópicas
ES2362525B8 (es) Formulación de medicamentos en forma de agujas percutaneas penetrantes.
BR112014009713A2 (pt) administração transdérmica de agentes bioativos de alta viscosidade
BR112015015699A2 (pt) composição aquosa injetável, método de preparação de uma composição aquosa injetável método para o tratamento ou prevenção de condições de dor e/ou inflamação e uso da composição
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112013022085A2 (pt) composição compreendendo receptor gama ativado por proliferador de peroxissoma
BR112012004696B8 (pt) composto modulador da atividade de tlr, seu uso, composição farmacêutica, medicamento, kit e combinação
MX2013002453A (es) Analogos deuterados de pridopidina utiles como estabilizadores dopaminergicos.
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
CA2716874A1 (en) A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
ECSP109960A (es) Gel conteniendo pirfenidona
IN2014DN09817A (es)
MX390536B (es) Composicion farmaceutica topica que comprende al menos amitriptilina para el tratamiento del dolor neuropatico periferico.
BR112013018739A2 (pt) sistema de distribuição de medicamento ocular
AR063088A1 (es) Uso del factor de crecimiento epidermico para la restauracion morfofuncoional de nervios perifericos en la neuropatia diabetica
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
MX376783B (es) Liposomas que encapsulan un autoantígeno y su uso en la prevención y/o el tratamiento de enfermedades autoinmunes.
BR112015018200A2 (pt) composição mastigável para administração oral e processo para preparar a mesma
ECSP10010567A (es) Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administracion de dronedarona
BR112014018426A8 (pt) Composição e dispositivo para administração transdérmica, e, método para administrar uma progestina
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
PH12015501538A1 (en) Topical ocular analgesic agents
NI201200196A (es) Agentes terapéuticos 976